Top-Line Data Show CV Benefit for Liraglutide in Type 2 DiabetesTop-Line Data Show CV Benefit for Liraglutide in Type 2 Diabetes

Liraglutide is the third diabetes drug to show CV benefit and the first for the GLP-1 class. News Alerts

Source: Medscape Cardiology Headlines - March 4, 2016 Category: Cardiology Tags: Diabetes & Endocrinology News Alert Source Type: news